González Abós, Carolina
Lorenzo, Claudia
Archilla, Iván
Vidal-Robau, Nuria
Cuatrecasas, Miriam
Ausania, Fabio
Article History
Received: 9 July 2024
Accepted: 30 October 2024
First Online: 5 November 2024
Declarations
:
: The study was approved by the Comité de Ética de la Investigación con medicamentos (CEIm), the institutional review board (IRB) of our Institution. Protocol identification ID was HCB/2022/0095.
: Not Applicable.
: Patient consent was waived by the IRB (Comité de Ética de la Investigación con medicamentos, CEIm) due to the retrospective nature of the study and the non-interference of the study with clinical management.
: The authors declare no competing interests.